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Abstract 
Purpose: in recent years digital technology and wearable devices applied to seizure detection have 
progressively become available. In this study we investigated the perspectives of people living with 
epilepsy (PWE), caregivers (CG) and healthcare professionals (HP). We were interested in their 
current use of digital technology as well as their willingness to use wearables to monitor seizures. 
We also explored the role of factors influencing engagement with technology, including 
demographic and clinical characteristics, data confidentiality, need for technical support and 
concerns about strain or increased workload. 
Methods: An online survey was constructed drawing on previous data collected via focus groups and 
was distributed via a web-link. Using logistic regression analyses, demographic, clinical and other 
factors identified to influence engagement with technology were correlated with reported use and 
willingness to use digital technology and wearables for seizure tracking.  
Results: 87 surveys were completed, fifty-two (59.7%) by PWE, 13 (14.4%) by CG and 22 (25.3%) by 
HP. Responders were familiar with multiple digital technologies, including the internet, smartphones 
and personal computers and the use of digital services was similar to the UK average. Moreover, age 
and disease-related factors did not influence access to digital technology. The majority of PWE were 
willing to use a wearable device for long-term seizure tracking. However, only a limited number of 
PWE reported current regular use of wearables, and non-users attributed their choice to uncertainty 
about the usefulness of this technology in epilepsy care. PWE envisaged the possibility of 
understanding their condition better through wearables and considered, with caution, the option to 
send automatic emergency calls. Despite concerns around accuracy, data confidentiality and 
technical support, these factors did not limit PWE’s willingness to use digital technology. CG 
appeared willing to provide support to PWE using wearables and perceived a reduction of their 
workload and anxiety. HP identified areas of application for digital technologies in their clinical 
practice, pending an appropriate reorganization of the clinical team to share the burden of data 
reviewing and handling. 
Conclusions: Unlike people suffering from other chronic health conditions, PWE appeared not to be 
at risk of digital exclusion. This study highlighted a great interest in the use of wearable technology 
across epilepsy service users, carers and health professionals, which was independent of 
demographic and clinical factors and outpaced data security and technology usability concerns. 
 
Keywords: epilepsy, wearable technology, stakeholders’ view, seizure detection  
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1. Introduction 
Epilepsy is one of the most common neurological disorders, affecting about 0.6% of the population 
worldwide [1]. It is characterized by recurrent seizures which are typically unprovoked and 
apparently unpredictable [2]. The management and treatment of epilepsy are mainly guided by the 
assessment of seizure recurrence and frequency. In routine clinical practice, seizure tracking relies 
on subjective patient recall and self-reporting, which is known to be extremely unreliable [3]. In the 
diagnostic setting the gold standard for seizure detection is electroencephalography (EEG), in 
combination with video monitoring. The EEG equipment is obtrusive and uncomfortable for long 
term use, and its application in everyday life seizure monitoring is considered unacceptable [4]. 
The last decade has seen an explosion in the capability of monitoring individuals via sensors built 
into smartphones or wearable devices. Remote health measurement technologies (RMT), defined as 
any mobile technology that enables the monitoring of an individual’s health status through a remote 
interface [5], allows a non-invasive and continuous assessment over time in non-traditional 
healthcare settings [6,7]. Novel applications of mobile technologies include the possibility to record 
non-EEG signals which may help in measuring seizure-induced clinical manifestations [8]. An 
objective and continuous collection of information on seizure occurrence, frequency and distribution 
would guide a more tailored management and inform decisions on treatment optimization. 
However, the successful adoption of RMT and its implementation in conventional healthcare 
systems might present challenges. Engagement with target users and acceptability in terms of 
adoption is key. Information about whether people with epilepsy (PWE) have access to digital 
services and technology is lacking. Previous studies have suggested that some health conditions may 
be a barrier to the use of digital technologies with an indication that this may particularly be the case 
in chronic conditions [9]. Robotham et al. [9] found that demographic variables, in particular age, 
may further explain some of the reasons for inequalities in use. Costs in terms of concerns about 
confidentiality and need for technical support have been highlighted as important potential barriers 
for engagement that need to be balanced against perceived utility [Simblett et al, unpublished]. 
There is a limited number of investigations exploring the willingness of people living with epilepsy 
(PWE) to use digital technologies for seizure detection and factors influencing their attitudes [10-12]. 
This study explores these factors in greater depth. However, it is not just individual users who are 
important, we also need to know about the likely support they may be offered. Therefore, we 
included caregivers (CG) and healthcare professionals (HP) working in the epilepsy field and also 
asked them about their use and willingness to use digital technologies to support someone living 
with epilepsy. Anticipated concerns about increased workload from previous research [13] were 
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investigated. The final part of this paper explored features to support the design of acceptable 
digital RMT in the future. 
2. Methods 
2.1 Survey instrument 
An online survey was constructed drawing on previous data collected via focus groups conducted on 
the topic (unpublished data) and was reviewed by our patient advisory board who made some 
suggested changes to the vocabulary and layout of the survey.  Respondents were asked about their 
(a) current use of digital services and devices; (b) their willingness to use digital services and devices, 
including the benefits and concerns of recording seizures with a device; and (c) more practical 
information about useful parameters to be monitored, receiving the information from a device and 
need for technical support (including recharging and upgrading devices). Following this common 
framework, the questions were specifically adapted for each group (surveys available in 
Supplementary material). 
2.2 Recruitment process 
The survey and study procedures were approved by the London - Westminster Research Ethics 
Committee (16/LO/1513; IRAS project ID 208970). The survey was distributed via a web-link. 
Participants were recruited via two NHS Trusts (King’s College Hospital (KCH) and South London and 
Maudsley (SLaM) NHS Foundation Trusts), charities (Epilepsy Action, Epilepsy Research UK), other 
non-NHS organisations (Independence Homes, the Institute of Mental Health at the University of 
Nottingham, ILAE-British chapter, IBE newsletter) as well as from databases held by King’s College 
London (KCL), KCH and SLaM. Further web links were posted on the RADAR-CNS website 
(https://www.radar-cns.org/news-events/we-want-hear-you), affiliated clinical research groups 
(MindTech, Institute of Mental Health, University of Nottingham) and related social media channels. 
Participants had the option to request a paper version of the survey by contacting the recruiting 
organizations. 
2.3 Statistical analysis 
After providing a descriptive analysis of the data we carried out specific correlations between 
variables noted to affect an individual’s response to using digital technology and wearable devices, 
including age. The role of clinical variables, including disease duration, seizure type (convulsive, 
including patients with associated focal seizures, versus non-convulsive) and seizure frequency was 
also explored. Similarly, demographic characteristics (age and gender), clinical characteristics 
(disease duration, seizure type and seizure frequency) and factors identified to influence 
engagement, including confidentiality and need for technical support were correlated with the 
reported willingness to use digital technology and wearables for seizure tracking. Quantitative data 
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were processed using logistic regression analyses in STATA version 14.0 (StataCorp, College Station, 
TX, U.S.A.). We also report relevant quotes from participants, highlighting perceptions about the use 
and acceptability of digital technology and devices. 
 
3. Results 
A total of 213 people clicked on a link to access the survey from April 2017 to September 2017. 
However only 87 (40.8%) gave consent and completed the whole survey. Fifty-two (59.7%) were 
PWE, 13 (14.4%) CG and 22 (25.3%) HP.  
3.1 Sample characteristics 
General demographic characteristics of the participants are reported in table 1. 
3.1.1 People with epilepsy 
The majority of PWE were aged under 40 and were women. Clinical characteristics are summarized 
in table 2. 
3.1.2 Caregivers 
CG had been taking care of PWE for 6.04.2 years on average (range 1-13). The majority (84.6%) 
were unpaid and three (23.1%) had received formal training for their role. Eight (61.5%) were taking 
care of children with epilepsy and five (38.5%) of adults with epilepsy.  
3.1.3 Healthcare professionals 
Eleven HP (50.0%) were doctors (ten neurologists and one psychiatrist), seven (31.9%) epilepsy 
nurses, two (9.1%) service managers, one (4.5%) learning disability nurse and one (4.5%) medical 
student. The mean number of patients under the care of this group was 158 (38.3) and the mean 
years of experience in the field was 8.4 years (5.2, range 1-20). The majority (63.6%), worked in 
services for adults, six (27.3%) in services for children and two (9.1%) in both. 
 
3.2 Current use of digital services and devices 
The current experience with technology reported by PWE and CG is illustrated in figure 1. 
Smartphones, internet, wi-fi and personal computers were widely used among these groups and 
95.4% of our sample had experience with multiple technologies. Smartwatches were less well used 
and were not employed by any CG. When specifically asked about the use of wearable devices, thirty 
(57.7%) PWE did not own any wearable. The reasons were mainly uncertainty about their usefulness 
(21.1%, device cost (9.6%), availability (7.7%), appearance (3.8%) and burden/comfort (1.9%). 
Nevertheless, 19/30 (63.3%) were interested in wearables and had been thinking about purchasing 
one. Of the 22 (42.3%) PWE who already owned one, 20 (38.5%) were using it regularly. These 
wearables were mainly used for exercise tracking and general health monitoring but there was a 
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range of other uses (see figure 2). Among the device features and functionality influencing the 
choice of the device they owned (figure 3) the similarity to a normal watch, the possibility to track 
movement, heart rate (HR) and app features were the most important. Other optional monitoring 
such as sweating or body temperature or being waterproof was less influential on their choice. 
Only three (23.1%) CG reported that they were taking care of someone using a wearable device 
regularly, and eight (61.5%) reported that they were taking care of PWE (children and adults) who 
were thinking about using a wearable. All the HP group were familiar with at least one digital service 
such as online guidelines (Microguide, upto date), calculation (MedCalc), prescribing/dosing (BNF or 
similar) and communication (NHS.net, WhatsApp) apps. Forty-five percent of HPs used smartphone 
apps with their patients, mainly to assist with condition management. Although HPs felt that data 
from wearables might be useful to enrich their understanding of a patient’s health state in between 
consultations (68.2%) and adherence to medications (50.0%), 40.0% admitted that this information 
was rarely or never used or discussed in the clinic during the consultations. Half the group had 
counselled patients on the use of technology and had specifically recommended bed alarms and 
smartphones or smartwatch apps to help with medication compliance and seizure reporting (e.g. e-
diaries). 
 
3.2.1 Factors influencing the current use of digital technology and wearable devices 
The use of digital services by PWE and CG was unrelated to participants’ age (p=0.8) and gender 
(p=0.7). For PWE, the current use of wearable devices was unrelated to epilepsy duration (p=0.2), 
seizure type (p=0.2) or frequency (p=0.5). 
 
3.3 Willingness to use digital technology and wearable devices 
The majority of PWE (80.0%) were willing to use a wearable device for seizure tracking. When asked 
what type of device would be acceptable for seizure recording/detection in the medium term 
(weeks) and long term (years), the majority (>69.0%) in each group indicated either a smartphone or 
a smartwatch (figure 4). A plain wristband (with no watch face), a ring-styled wearable or a sensor 
under the mattress were additional options for PWE and HP. Headbands and small EEG electrodes 
were less favoured: 
PWE10: “I would be willing to wear some form of EEG if in a private setting. I would therefore 
not be able to wear this for most of the day, or on a regular schedule” 
 
Comments related to the device being discreet were provided by each group.  
PWE21: “I feel it's important that any wearable devices look as 'normal' as possible.  
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Speaking from personal experience, they can be big, bulky, uncomfortable and an eyesore. 
It is important to feel dignified, which can be difficult enough during a seizure, let alone when 
someone drapes a huge buzzer around your neck!”  
CG05: “They need to be non-stigmatising” 
HP12: “Any device developed must fit in with the current fashion, people don't want to wear 
devices that make them stand out as having a disability”  
HP19: “It needs to be non-intrusive” 
 
Forty-eight (92.3%) PWE reported that they would be willing to use a wearable to monitor seizures 
for as long as necessary to get an accurate measurement and two (3.7%) for many months.  
 
3.3.1 Factors influencing the willingness to use wearable devices for seizure tracking  
For PWE, age, gender, epilepsy duration and seizure type and frequency did not influence the 
willingness to use any of the device options provided (p>0.05). 
 
3.4 Benefits of recording seizures on a device  
When asked to rank the greatest benefit of having seizures recorded, PWE prioritised:  
i. having the information for their own knowledge (59.6%) 
PWE10: “…I would like some way to keep track of [..] frequent symptoms and understanding 
their mechanism and any potential patterns or prompts, ideally in way beyond simply timing 
them” 
PWE11: “I am never sure how many seizures I really have so anything to monitor them would 
be helpful” 
ii. being able to share the information with their doctor (48.1%) 
PWE44: “It would be beneficial to the individual also real time information for healthcare 
professionals” 
iii. having a device that alerts relatives when you have a seizure (36.5%) 
PWE13: “I think it is something that is really needed for people like me who live alone and 
are very active doing outdoor activities alone or even for people going out on hikes etc. 
alone. For me, this will lessen my concerns and anxiety” 
 
Less preferable options were: having a device that can alert medical services (26.9%), having the 
information available to discuss with your employer (19.2%), having the information available to 
discuss with welfare benefits services (15.4%): 
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PWE18: “I am interested in the health and safety benefits to prove to work that I am not a 
hazard” 
 
3.5 Concerns about using digital technology and wearable devices 
3.5.1 Confidentiality 
When asked about information and data confidentiality, 31 PWE (59.6%) reported concerns about 
the information not being confidential with nearly half stating specific concerns about privacy, a 
third for the lack of control over the information and just one quarter because of potential negative 
effects on their work or their ability to drive. Only four CG (30.8%) reported concerns about the 
information not being confidential, three about the lack of control over the information and one 
about potential negative effect on their work. 
3.5.1.1 Correlations between confidentiality and the willingness to use wearable devices for seizure 
tracking  
For both PWE and CG, age (p=0.3), gender (p=0.3) and current use of digital technology (p=0.4) did 
not impact on concerns about data confidentiality. Moreover, for PWE, concerns about 
confidentiality did not influence their willingness to use wearable devices (p=0.7). 
 
3.5.2 Need for technical support 
Only a small proportion of PWE (28.8%) considered technical support unnecessary. PWE (48.0%) and 
CG (53.8%) preferred technical support to be provided in a written document or video tutorial, while 
HP favoured person to person training (63.6%). The majority of PWE (59.6%) would accept to 
recharge the device once a day and to upgrade the apps once a week (48.1%) or monthly (30.8%). 
CG (69.2%) would be keen to assist PWE during these procedures. 
3.5.2.1 Correlations between need of technical support and the willingness to use wearable devices 
for seizure tracking  
For both PWE and CG, age (p=0.1), gender (p=0.2) and current use of digital technology (p=0.1) did 
not influence the need for technical support. Of note, PWE currently using a wearable device 
reported less need for support, although this trend was not statistically significant (p=0.09). The 
need for technical support did not influence PWE’s willingness to use wearable devices (p=0.7). 
 
3.5.3 Strain or burden of workload 
CGs responded that the decision of PWE to wear a device to monitor seizures would reduce their 
strain/workload as this would (i) provide valuable and helpful information to identify seizures or 
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triggers, (ii) give warnings, (iii) reduce anxiety and (iv) represent a potentially accurate and objective 
tool to help with communication with the healthcare system as compared to subjective reporting: 
CG05: “Reduce worry for carer and increase the independence for person with epilepsy” 
CG11: “If it told me when he was having a seizure we would not have to constantly watch 
him to record seizures. I would not have to worry if my timing was accurate as it would be 
accurately recorded as would his heart rate and if a trip to hospital was needed you have an 
accurate picture of what happened to help the health professionals. It may also help with an 
understanding of when these seizures happen and why”  
 
HPs believed that digital devices could help with patients’ management (68.2%), especially at 
specific decision points such as treatment initiation/adjustment and diagnosis (providing contextual 
data), as well as helping patients self-management (63.3%). However, half reported a perceived 
increase in workload related to the time required for reviewing data and to manage patients’ anxiety 
about their data. HPs identify the epilepsy nurse as the most appropriate figure to deal with 
wearable technology data within the epilepsy team: 
HP12: “They are closer to the patient's everyday needs than the neurologist”  
HP19: “Easiest to access for patient” 
HP22: “I am (epilepsy nurse) the first point of contact for patients when their epilepsy is not 
under control, this data will be useful in making planned changes to treatment before the next 
planned appointment”. 
 
3.6 Designing acceptable technology 
3.6.1 Measurement parameters 
When provided with a list of parameters they would considered more useful to help track seizures in 
the long term (figure 5), all groups selected body movements, heart rate, breathing rate and sleep 
quality. The majority of PWE favoured multiple parameters if measured simultaneously through the 
same device:  
PWE07: “A device that monitored heart rate, temperature and menstrual cycle. I have learnt 
a lot about my triggers over the years from gathering this kind of information”  
PWE42: “I currently track my menstrual cycle and daily basal body temperature to gather 
information and regularly check my heart and stress rate using various apps on my 
smartphone but I feel like the technology is there to be able to track all these things but it 
needs bringing together in a single device”. 
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Less preferable options were location monitors such as GPS, how many time the smartphone is used 
and voice quality. CG appeared to be less in favour of mood, concentration, attention and memory, 
while HP were less interested in monitoring skin temperature and environmental factors than PWE. 
Further desirable features for PWE were stress levels, medication taken, fluid intake, alcohol 
drinking and oxygen saturation while HP suggested mental state, emotion, stress, blood sugar and 
observations made by family and friends. 
One of the participants in the PWE group expressed the need to extend seizure detection to 
different seizure types: 
PWE52: “The majority of seizure detection devices available focus on tonic-clonic seizures. The 
majority of my seizures are complex partial seizures and there is very little research in this area. 
These are the seizures when I feel most vulnerable and are the hardest to control through 
medication. A greater focus on these would be ideal” 
 
3.6.2 Data accessibility and use  
Having the information constantly sent to a computer was preferred by PWE (55.8%) and CG (53.8%) 
rather than the option of having the information stored in the device and then downloaded onto a 
computer (38.4% PWE and 23.1% CG). PWE valued the possibility to receive real time feedbacks 
from the device (46.1%) and were less in favour of a device feature which triggered alarms (19.2%), 
alerting care providers (11.5%) or relatives, caregivers or friends (7.7%). Conversely, CG were in 
favour of a device able to trigger an alarm (61.5%) or able to send the information collected 
immediately to the doctor (53.8%). 
The data collected by wearable technologies would be mainly used by HP to assess seizures/post-
seizure events (40.9%). Other options included in preparation for a consultation with a patient 
(36.4%), during consultation with a patient (36.4%) and in between consultations (27.3%). Having 
the information available during the consultation through direct access to data on the device and 
having the information available automatically via a secure patient portal were considered better 
options compared to having the information available at the patients’ discretion or via notification 
when the system detects a change in patient health state. 
 
4. Discussion 
In recent years wearable solutions applied to seizure detection have progressively become available. 
This study aimed to assess PWE access to digital and wearable technology and to identify factors 
influencing acceptability of digital tools in epilepsy care. We also explored whether PWE and those 
that support them, including CG and HP, are concerned with similar potential barriers and 
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facilitators to engagement, including factors already identified to influence engagement: 
confidentiality, need for technical support and concerns about strain or increased workload. 
Although generalizability might be limited, our results reflect the view of a population who might 
benefit from the use of this technology: PWE with active, refractory seizures (mostly TC); CG of 
children (more vulnerable and more likely represented by caregivers); HP with years of experience in 
the epilepsy services. We are aware that the limited number of CG and HP taking part in this survey 
and more data from these groups are needed to better characterize their views. 
 
4.1 Current use of digital technology and wearable devices 
Our sample’s access and familiarity with multiple digital technologies was high. PWE access to the 
internet (92.3%) was similar to the UK average (87.9% in 2016) [14] and the prevalence of 
smartphone ownership (85.6%) was also similar to the national average (88.0%) [15]. In contrast 
with people suffering from other chronic health conditions [9], PWE seemed to have a lower risk of 
digital exclusion. Furthermore, age and other factors did not influence their access to digital 
technology. Nevertheless, these findings should be considered with caution. Although an option to 
access a paper version was provided, the survey was advertised online, therefore PWE who are 
more familiar with digital technology might have had easier access to the survey and a higher chance 
of being enrolled.  
Compared to the access to the internet and smartphones, the use of wearables appeared more 
limited and only 38.3% of PWE owned a smartwatch. National statistics on wearable devices 
ownership are not available. In our sample, wearables were mainly employed for exercise and 
general health tracking, reflecting the use of this technology in the general population and impacting 
on favourite features (“movement” and “HR”) ranking. The use of wearables for epilepsy monitoring 
was reported by a minority of participants and responders disclosed some uncertainty about the 
usefulness, application and availability of this technology to their care. The lack of evidence-based 
recommendation regulating the use of wearables in epilepsy care may explain this result as well as 
HPs’ reluctance to recommend wearables. 
 
4.2 Willingness and factors influencing the use of digital technology and wearable devices 
Despite only a limited proportion of our PWE (38.5%) reporting a regular use of wearables, the 
majority (80.0%) expressed an interest in using a device, confirming the presence of a dissociation 
between the small user group and a potential larger user group reported by previous investigations 
[10,11]. Devices commonly used in daily life by healthy individuals, such as smartphones and 
smartwatches, were indicated as the most acceptable for seizure detection, a finding that appeared 
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in line with other studies [10,12]. Conversely, less common and less discreet solutions (headband, 
EEG electrodes) were perceived as more stigmatizing in a daily-life setting, as clearly stated by 
participants in the free text comments. Overall, PWE appeared in favour of a long-term use of 
wearables, as emphasized in a similar study [11], and our patients were willing to use wearables as 
long as necessary to get accurate measurements. This answer and the uncertainty about the 
usefulness of wearables expressed by current non-users suggest that accuracy represents a key 
concern for patients.  
A majority of PWE manifested concerns related to data safety, especially for the consequences that 
privacy breach could have on daily life and restriction of freedom, including driving, work and 
insurance. Despite its importance, data security has been rarely addressed in previous investigation 
in PWE and only one study considered confidentiality important [10]. 
The need for technical support appeared minimal in our population and the familiarity with digital 
technology appeared to positively influence user’s independence. 
Of note, demographic and clinical factors did not influence PWE’s willingness to use wearables, 
including concerns related to data confidentiality and need for technical support. 
 
4.3 Benefit and concerns about using digital services and devices 
PWE considered the possibility to acquire information that could help improve their knowledge of 
their condition as the major benefit of using a wearable device. Contrary to our hypothesis that 
technology may increase strain or workload burden, CG considered the wearable solutions as a tool 
to alleviate the anxiety related to the responsibility of being constantly monitoring PWE and to 
improve communication with healthcare providers via objective reporting.  
HP seemed keen to integrate wearable technology data into specific decision points although they 
identified a data handling and reviewing burden. Novel technologies should be endorsed by 
dedicated figures within the epilepsy care team, such as the epilepsy nurse, as also pointed-out in a 
recent review on RMT adoption into primary care [13]. 
 
4.4 Designing acceptable technology 
4.4.1 Measurement parameters 
Apparently in contrast with the preferred small form factor, PWE expressed the need to incorporate 
and integrate many measurements (active and passive) and sensors into a single device. PWE’s 
experience of a variety of seizure-related physiological manifestations and precipitants informed 
their selection and was also reflected in the overlapping HPs’ preferences. Wearable application was 
not exclusively confined to seizure detection rather extended to seizure risk assessment, through 
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combining physiological and contextual information. As underlined before [16], the potential role of 
less well recognized parameters such as sweating and voice quality was not so much valued. 
Conversely, stress was suggested as an additional feature. In contrast with the view of PWE and HP, 
CG were less interested in tracking mood, concentration, attention and memory. We can speculate 
that our sample of CG mainly dealing with children might have been exposed to less significant 
behavioural and cognitive alterations as compared to adult populations. 
4.4.2 Data accessibility and use  
PWE mainly opted for direct and automatic data streaming and appeared willing to share the 
information with their doctors and to receive direct feedback. Surprisingly, only a minority (26.9%) 
considered beneficial the option to send alarms, in contrast with previous research reporting higher 
proportions (68.7% [10], >50% [12]). Although we cannot exclude the role of sample characteristics 
and methodology and despite our survey not specifically addressing this topic, we believe that the 
limited interest in sending alarms may reflect a degree of uncertainty about data accuracy, the 
possibility to receive false alarms [11, 12] and probably the awareness that assistance and 
emergency call are not required for all seizures. The choice of alerting relatives for immediate 
support rather than doctors also pointed towards the same direction and reflected the view 
provided by other studies [10, 11]. In addition, we cannot exclude that PWE perceived device-
generated warnings as an additional “uncontrolled” factor potentially increasing the fear related to 
seizure unpredictability [17-19] mentioned by one subject in our survey PWE18: “I lived in fear of 
when the next one would be”. 
In contrast with this, CG would prefer the device to trigger an alarm and alert doctors, confirming 
previous findings [17]. 
 
4.5 Unmet needs 
Although only mentioned by a minority in our sample, the need for research focused on non-
convulsive seizures and seizures with preserved awareness appeared extremely relevant and echoed 
similar views expressed for both seizure detection [11, 16] and prediction [4]. Despite equally 
affecting PWE’s life, seizures considered as less severe and less life-threatening have not received 
adequate attention and identifying seizure types that do not exhibit limb movements still represents 
a challenge [20]. 
 
5. Conclusions 
Wearables currently represent a field of investigation not yet incorporated into routine epilepsy 
care. The successful implementation of digital tools cannot disregard accessibility and acceptability 
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of the technology to users or their engagement with it. Our survey indicated that PWE seem to have 
a good access to digital technology and are interested in the long-term use of preferably small, 
commonly used, multimodal wearable devices. However, data accuracy was a key concern for users 
and this should be taken into account in the design of acceptable devices for seizure detection.   
Despite concerns around data confidentiality and technical support, these factors were not limiting 
PWE’s willingness to use the technology. When a broad range of potential use-cases was presented, 
PWE favoured the possibility to acquire information in the attempt to mitigate seizure 
unpredictability over the option to generate automated emergency calls, which is currently 
considered the major benefit of RMT application in epilepsy. 
Many encouraging messages emerged from this work, underlining the interest in research exploring 
the role of wearables in epilepsy. Nevertheless, in order to meet service users’ needs and have an 
impact on PWE wellbeing, further efforts are needed to incorporate multiple measurements into a 
single device and to improve the capability to detect a wider range of seizure types. 
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Table 1. Demographic characteristics of the participants (N=87)  
 
Characteristics PWE 
(N, %) 
Caregivers 
(N, %) 
Healthcare 
professionals 
(N, %) 
Number 52 13 22 
Age group    
Under 20 2 (3.8) 0 (0.0) 0 (0.0) 
20-29 9 (17.3) 2 (15.3) 2 (9.1) 
30-39 25 (48.1) 4 (30.8) 10 (45.4) 
40-49 5 (9.6) 4 (30.8) 4 (18.2) 
50-59 11 (21.2) 3 (23.1) 5 (22.7) 
60-69 0 (0.0) 0 (0.0) 1 (4.6) 
Gender    
Female 43 (82.7) 12 (92.3) 14 (63.6) 
Employment    
Full-time 20 (38.5) 6 (46.1) 21 (95.5) 
Part-time 10 (19.2) 4 (30.8) 0 (0.0) 
Unemployed 20 (38.5) 3 (23.1) 1 (4.5) 
Retired 2 (3.8) 0 (0.0) 0 (0.0) 
 
PWE: people with epilepsy 
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Table 2. Clinical characteristics of PWE (people with epilepsy, N=52)  
 
Clinical characteristics  (N, %) 
Disease duration (years) meanSD 16.713.8 
Seizure frequency (seizure/month) median (range) 2 (0-210) 
Seizure type (last two years)  
Tonic-clonic 33 (63.5) 
Focal 16 (30.7) 
Tonic 25 (48.1) 
Myoclonic 2 (3.8) 
Absence 9 (17.3) 
None 2 (3.8) 
Number of AEDs  
One 17 (32.7) 
Two 20 (38.5) 
Three or more 13 (25.0) 
None 2 (3.8) 
Non-pharmacological treatment  
Epilepsy surgery 4 (7.7) 
Vagus nerve stimulation 4 (7.7) 
Deep brain stimulation 1 (1.9) 
Time to full recovery after a seizure  
1hour 21 (40.4) 
>1 hour and <1 day 20 (36.5) 
Many days 11 (21.1) 
AEDs: anti-epileptic drugs, SD: standard deviation 
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Figures legend 
 
Figure 1. Which of the following technologies do you currently use? 
PWE: people with epilepsy 
Figure 2. For what purposes do you use your wearable device? 
 
Figure 3. What features influenced your wearable device selection? 
GPS: global positioning system; HR: heart rate. 
Figure 4. Which of the following do you think would be acceptable to use for detecting and 
recording seizures? 
PWE: people with epilepsy 
Figure 5. Which of the following would you agree could be useful to be recorded over a long period 
of time (at least a year) to help to keep track of seizures?  
PWE: people with epilepsy 
 
 
 
 
  
 
 
 
 
 
 
